Hemostasis and Tissue Sealing Agents Market
Hemostasis and Tissue Sealing Agents Market Analysis By Product (Topical Hemostats, Adhesive & Tissue Sealants), By End User (Hospitals, Ambulatory Surgery Centers, Home Care Settings, Others), & By Region - Global Market Insights 2022-2027
Analysis of Hemostasis and Tissue Sealing Agents market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Hemostasis and Tissue Sealing Agents Market Outlook (2022-2027)
The global hemostasis and tissue sealing agents market is expected to increase at a high CAGR of 8.5% and climb from a market valuation of US$ 5 billion in 2022 to US$ 7.6 billion by the end of 2027.
Global sales of topical hemostats are predicted to rise at an impressive CAGR of 9.5% owing to the rising prevalence of chronic blood disorders across the world.
Report Attributes |
Details |
|---|---|
|
Hemostasis and Tissue Sealing Agents Market Size (2022E) |
US$ 5 Billion |
|
Forecasted Market Value (2027F) |
US$ 7.6 Billion |
|
Global Market Growth Rate (2022-2027) |
8.5% CAGR |
|
China Market Growth Rate (2022-2027) |
13% CAGR |
|
Key Companies Profiled |
|
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Demand Analysis of Hemostasis and Tissue Sealing Agents (2017-2021) Vs. Market Forecasts (2022-2027)
Hemostats and sealants are medical equipment used to stop bleeding and haemorrhage brought on by wounds and surgical operations. They are extremely helpful aids to contemporary surgical techniques. However, severe blood loss that results from serious surgery or trauma cannot be prevented by the body's normal healing mechanisms.
Hemostats and tissue sealing agents help in such circumstances by reducing blood loss and promoting wound healing. The first stage of hemostasis wound healing can last for 2 days. Ice can aid with acute discomfort from haemarthrosis; other treatments can be used that won't affect hemostasis and coagulation.
Topical hemostats, such as active hemostats, mechanical hemostats, and flowable hemostats–solutions administered topically are directly applied to the bleeding site–along with natural and artificial tissue sealants serve as an addition to the body's normal hemostasis process and are used locally to control bleeding.
Topical hemostats are used primarily intraoperative and less frequently postoperatively. Also, bone bleeding, gushing venous type bleeds, raw surface bleeding, and needle-opening bleeding can all be treated with these products.
A typical hemostasis valve features a rotating seal at the end that can be opened or closed in response to the insertion or removal of a wire, microcatheter, or guidewire. This frequently causes considerable back bleeding.
Due to a rise in demand supported by increasing surgical volumes, the market is anticipated to have profitable growth over the next five years. Among the main factors influencing the market are the rise in the elderly population and the high frequency of chronic diseases.
During the forecast period of 2022 to 2027, the global market share of hemostasis and tissue sealing agents is expected to experience significant growth due to the increase in the use of hemostats product lines to prevent blood loss in a variety of general as well as less invasive surgical interventions and the preference for minimally-invasive procedures over other traditional procedures.
According to this market study of hemostasis and tissue sealing agents, by Fact.MR, a market research and competitive intelligence provider, the global market is expected to reach a valuation of US$ 7.6 billion by 2027.
What’s Augmenting Sales of Hemostasis and Tissue Sealing Agents?
“Market Gaining Prominence on Back of High Demand for Minimally-invasive Surgeries”
Demand for minimally-invasive procedures has significantly increased in recent years. Minimally-invasive operations include benefits such as shorter hospital stay, minimal incisions, fewer post-surgical problems, and quicker recovery time.
A majority of minimally-invasive procedures use systemic hemostatic agents such as gelatin- and collagen-based powder hemostatic agents. Complex procedures can be carried out easily due to these medications.
- Approximately 234.2 million major surgical surgeries are done annually by various hospitals and surgical centres around the world, according to a World Health Organization (WHO) study.
The need for hemostat and tissue sealing agents is therefore increased by the rising number of surgeries and the preference for minimally-invasive procedures.
“Increasing Incidence of Chronic Disorders Needing Surgery”
Patients who are elderly need immediate attention and are more likely to get wounds and injuries that take a long time to recover. The market is predicted to develop as a result of an increase in the number of common injuries and wounds due to a demographic trend toward an active lifestyle.
Most chronic conditions ultimately necessitate surgical procedures, which subsequently promote market growth. A few chronic illnesses that call for these goods are hernia fixation, diabetes, spinal injuries, urological disorders, ocular injuries and replacements, and burns.
These solutions were chosen over alternative wound closure techniques, which resulted in an expansion of their applications, particularly in endoscopic treatments. Endoscopic hemostatic therapy is effective for the treatment of peptic ulcers.
The market for hemostasis and tissue sealing products serves patients with everything from minor wounds to burns and neurosurgical treatment.
Hemostatic agents in surgery are particularly used in minimally-invasive urological procedures, which are supporting the market growth. Following general procedures, cardiovascular diseases see the biggest demand. Higher applicability in cardiovascular illnesses is attributable to sealants' and hemostats' superior clinical outcomes when compared to other wound closure methods.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What is Hampering Hemostasis and Tissue Sealing Agents Market Size Growth?
“High Production Cost & Strict Regulatory Requirements”
The development of hemostat and tissue sealant solutions is a time-consuming and expensive process. Regulatory approval of hemostat products requires reliable scientific proof, carefully monitored research, and case studies with documentation.
Although firms spend a lot of money developing hemostat products, there is a low success rate for getting these medications approved by regulatory bodies. The poor approval rate of hemostat solutions has been linked to the low efficacy and safety of the medications.
Due to difficulties hemostat manufacturers encountered in clinical research, only a few businesses have reached the market. The market for hemostasis and tissue sealing agents is hampered as a result.
How is the Start-up Ecosystem for Hemostasis and Tissue Sealing Agents Evolving?
“New Market Entrants Can Mimic Strategies of Key Players to Grow”
AVS Electrotherm, Ortholink Marketing, AGD Biomedicals, Globalstar Company, and Sysmex are a few of the start-up businesses that are vying for a share in the market.
To gauge the interest of potential customers and build a larger clientele, hemostasis and tissue sealing agent manufacturers are utilising a variety of marketing methods, including new product releases, geographic growth, partnerships, mergers and acquisitions, and collaborations.
- In terms of hemostasis instrumentation, Sysmex leads the world market. To create a mutually beneficial partnership that strengthens each party's advantages in the hemostasis market, Sysmex has maintained its distribution arrangement with Siemens, a world leader in hemostasis reagents.
New companies can follow the successful strategies of established companies to carve a space for themselves in this niche market.
Which Regions Account for High Demand for Hemostasis and Tissue Sealing Agents?
“North America & Asia Pacific Lead Global Market Handsomely”
The market for hemostasis and tissue sealing agents is dominated by the North America region due to the rising incidence of cancer, diabetes, and cardiovascular diseases.
Due to the rising frequency of various hemostasis illnesses, the involvement of regional and international industry players, and the significant investments made in R&D of hemostasis and tissue sealing agents, Europe also presents prospective growth possibilities in the hemostasis products market.
A significant growth rate in the Asia Pacific is anticipated between 2022 and 2027 as a result of an increase in surgical and medical tourism. Over the forecast period, an increase in traffic accidents in the Asia Pacific region that result in trauma admissions to emergency rooms also supports market expansion in the region.
- The Ministry of Road Transport and Highways, Government of India, reports that a total of 366,138 road accidents were reported during the year 2020, resulting in 131,714 fatalities and 348,279 injuries. Sadly, the age range most frequently impacted by traffic accidents is 18 to 45 years old, which accounts for around 70% of all accidental fatalities.
Latin America and the Middle East & Africa regions are expected to have relatively lower market shares and growth rates over the coming years.
Country-wise Analysis
What is Allowing the U.S. Hemostasis and Tissue Sealing Agents Market to Dominate North America?
“Increased Prevalence of Cardiovascular Illnesses & Blood Clotting Issues”
Due to growing healthcare infrastructure, widespread use of cutting-edge automated analyzers, and a sizable patient base, the U.S. currently holds a monopoly on the North America hemostasis and tissue sealing agents market.
- Sysmex Corporation introduced the Automated Blood Coagulation Analyzers CN-6000 and CN-3000 in 2018, which are next-generation analyzers in the hemostasis sector.
Furthermore, technological developments have made healthcare services more accessible, and the introduction of new manufacturers will probably drive market expansion in the nation in the coming years. Also, demand for hemostasis diagnostics is being aggressively driven up by the rising prevalence of several blood clot illnesses.
- The US Centers for Disease Control and Prevention (CDC) estimates that one in 5,617 live male births has hemophilia. In the US, there are 30,000 to 33,000 males who have hemophilia.
- According to the Centers for Disease Control and Prevention, one person in the United States passes away from cardiovascular disease every 34 seconds. In the United States, heart disease caused the deaths of almost 697,000 people in 2020, accounting for 1 in 5 deaths.
Will China Be a Lucrative Market for Hemostasis and Tissue Sealing Agents?
“Presence of Top Pharmaceutical & Biotechnology Businesses”
The most lucrative market is thought to be China, which is predicted to account for a higher market value. Due to its technologically advanced healthcare system, innovative therapies, and substantial patient population, China is predicted to lead the Asia Pacific hemostasis and tissue sealing agents market in terms of revenue share and grow at a significantly faster rate than other countries.
The presence of leading pharmaceutical and biotech firms engaged in the development of therapies is credited with the expansion of the hemostasis and tissue sealing agents market in China. Furthermore, the market is supported by a sound healthcare system. Also, there are chances for market expansion due to expanding cardiovascular disorder prevalence in the nation and rising hemostasis product demand.
The China hemostasis and tissue sealing agents market is expected to rise at a high CAGR of 13% from 2022 to 2027 and reach US$ 1.6 billion by 2027.
Category-wise Analysis
Why are Topical Hemostats Widely Popular?
“Cost-effective, Simple to Apply, & Effective End Results Make Topical Hemostats Popular Choice”
Topical hemostasis solutions are in demand because they are affordable, effective, simple to apply, and biodegradable. In surgical operations, topical hemostasis agents are most frequently used. Thus, the segmental expansion will be favoured by the rising number of surgical procedures.
The segment of infusible hemostats is expected to account for a sizeable market share during the projected period. When it comes to managing bleeding in patients with blood clotting disorders such as haemophilia, Von Willebrand disease (vWD), and dysfibrinogenemia, infusible hemostats are among the most popular and commonly used hemostatic medicines.
Global demand for topical hemostatic agents is predicted to rise at an impressive CAGR of 9.5% from 2022 to 2027 and reach a valuation of US$ 5.5 billion by 2027.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Competitive Landscape
The leading companies in the global hemostasis and tissue sealing agents market are involved in product launches, manufacturing technologically cutting-edge solutions, acquisitions, and joint ventures with other businesses.
These tactics are probably going to help the market for tissue sealing and hemostasis agents increase around the globe.
- The Terumo Corporation introduced AQUABRID, a novel surgical sealant product, to the EMEA market on January 26, 2020. Using this product during aortic surgery helps to halt bleeding.
- Johnson & Johnson (Ethicon, Inc.) (U.S) dominates the market for tissue sealants and tissue glue. The company enjoys a strong regional presence and a well-known brand. It also offers a wide variety of surgical sealants and adhesives, including some of the most recognizable brands.
Segmentation of Hemostasis and Tissue Sealing Agents Industry Research
-
By Product :
- Topical Hemostats
- Adhesive & Tissue Sealants
-
By End User :
- Hospitals
- Ambulatory Surgery Centers
- Home Care Settings
- Others
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product modifications /Innovation 4. Key Success Factors 4.1. Strategic Developments 4.2. Key regulations 4.3. Product USPs /Technology 4.4. List of Manufacturers and Providers 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP outlook 5.1.2. Increasing R&D Expenditure 5.2. Forecast Factors - Relevance & Impact 5.2.1. New Product launches 5.2.2. Cost of Products 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID19 Crisis Analysis 6.1. Current COVID19 Statistics and Probable Future Impact 6.2. Current GDP Projection and Probable Impact 6.3. Current Economic Projection as Compared to 2008 Economic analysis 6.4. COVID19 and Impact Analysis 6.4.1. Revenue By Product 6.4.2. Revenue By End User 6.4.3. Revenue By Country 6.5. 2021 Market Scenario 6.6. Quarter by Quarter Forecast 6.7. Projected Recovery Quarter 7. Global Hemostasis and Tissue Sealing Agents Market Volume (Units) Analysis 2017-2021 and Forecast, 2022-2027 7.1. Historical Market Volume (Units) Analysis, 2017-2021 7.2. Current and Future Market Volume (Units) Projections, 2022-2027 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Hemostasis and Tissue Sealing Agents Market - Pricing Analysis 8.1. Regional Pricing Analysis By Product 8.2. Pricing Break-up 8.2.1. Manufacturer Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 9. Global Hemostasis and Tissue Sealing Agents Market Value Analysis 2017–2021 and Forecast, 2022-2027 9.1. Historical Market Value (US$ Mn) Analysis, 2017–2021 9.2. Current and Future Market Value (US$ Mn) Projections, 2022-2027 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Hemostasis and Tissue Sealing Agents Market Analysis 2017–2021 and Forecast 2022-2027, by Product 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Products & Services, 2017–2021 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022-2027 10.3.1. Topical Hemostats 10.3.2. Adhesive & Tissue Sealants 10.4. Market Attractiveness Analysis By Product 11. Global Hemostasis and Tissue Sealing Agents Market Analysis 2017–2021 and Forecast 2022-2027, by End User 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By End User , 2017–2021 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User , 2022-2027 11.3.1. Hospitals 11.3.2. Ambulatory Surgery Centers 11.3.3. Home Care Settings 11.3.4. Others 11.4. Market Attractiveness Analysis By End User 12. Global Hemostasis and Tissue Sealing Agents Market Analysis 2017–2021 and Forecast 2022-2027, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2017–2021 12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2027 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. East Asia 12.3.5. South Asia 12.3.6. Oceania 12.3.7. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America Hemostasis and Tissue Sealing Agents Market Analysis 2017–2021 and Forecast 2022-2027 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 13.3.1. By Country 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Product 13.3.3. By End User 13.4. Market Attractiveness Analysis 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. Latin America Hemostasis and Tissue Sealing Agents Market Analysis 2017–2021 and Forecast 2022-2027 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Product 14.3.3. By End User 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. Europe Hemostasis and Tissue Sealing Agents Market Analysis 2017–2021 and Forecast 2022-2027 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. Russia 15.3.1.7. Rest of Europe 15.3.2. By Product 15.3.3. By End User 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. South Asia Hemostasis and Tissue Sealing Agents Market Analysis 2017–2021 and Forecast 2022-2027 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Product 16.3.3. By End User 16.4. Market Attractiveness Analysis 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. East Asia Hemostasis and Tissue Sealing Agents Market Analysis 2017–2021 and Forecast 2022-2027 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.1.4. Rest of East Asia 17.3.2. By Product 17.3.3. By End User 17.4. Market Attractiveness Analysis 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Oceania Hemostasis and Tissue Sealing Agents Market Analysis 2017–2021 and Forecast 2022-2027 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Product 18.3.3. By End User 18.4. Market Attractiveness Analysis 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Hemostasis and Tissue Sealing Agents Market Analysis 2017–2021 and Forecast 2022-2027 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. South Africa 19.3.1.3. Rest of Middle East and Africa 19.3.2. By Product 19.3.3. By End User 19.4. Market Attractiveness Analysis 19.5. Drivers and Restraints - Impact Analysis 20. Key and Emerging Countries Hemostasis and Tissue Sealing Agents Market Analysis 2017–2021 and Forecast 2022-2027 20.1. Introduction 20.1.1. Market Value Proportion Analysis, By Key Countries 20.1.2. Global Vs. Country Growth Comparison 20.2. U.S. Hemostasis and Tissue Sealing Agents Market Analysis 20.2.1. By Product 20.2.2. By End User 20.3. Canada Hemostasis and Tissue Sealing Agents Market Analysis 20.3.1. By Product 20.3.2. By End User 20.4. Mexico Hemostasis and Tissue Sealing Agents Market Analysis 20.4.1. By Product 20.4.2. By End User 20.5. Brazil Hemostasis and Tissue Sealing Agents Market Analysis 20.5.1. By Product 20.5.2. By End User 20.6. U.K. Hemostasis and Tissue Sealing Agents Market Analysis 20.6.1. By Product 20.6.2. By End User 20.7. Germany Hemostasis and Tissue Sealing Agents Market Analysis 20.7.1. By Product 20.7.2. By End User 20.8. France Hemostasis and Tissue Sealing Agents Market Analysis 20.8.1. By Product 20.8.2. By End User 20.9. Italy Hemostasis and Tissue Sealing Agents Market Analysis 20.9.1. By Product 20.9.2. By End User 20.10. Spain Hemostasis and Tissue Sealing Agents Market Analysis 20.10.1. By Product 20.10.2. By End User 20.11. BENELUX Hemostasis and Tissue Sealing Agents Market Analysis 20.11.1. By Product 20.11.2. By End User 20.12. Russia Hemostasis and Tissue Sealing Agents Market Analysis 20.12.1. By Product 20.12.2. By End User 20.13. China Hemostasis and Tissue Sealing Agents Market Analysis 20.13.1. By Product 20.13.2. By End User 20.14. Japan Hemostasis and Tissue Sealing Agents Market Analysis 20.14.1. By Product 20.14.2. By End User 20.15. South Korea Hemostasis and Tissue Sealing Agents Market Analysis 20.15.1. By Product 20.15.2. By End User 20.16. India Hemostasis and Tissue Sealing Agents Market Analysis 20.16.1. By Product 20.16.2. By End User 20.17. ASEAN Hemostasis and Tissue Sealing Agents Market Analysis 20.17.1. By Product 20.17.2. By End User 20.18. Australia Hemostasis and Tissue Sealing Agents Market Analysis 20.18.1. By Product 20.18.2. By End User 20.19. New Zealand Hemostasis and Tissue Sealing Agents Market Analysis 20.19.1. By Product 20.19.2. By End User 20.20. GCC Countries Hemostasis and Tissue Sealing Agents Market Analysis 20.20.1. By Product 20.20.2. By End User 20.21. Turkey Hemostasis and Tissue Sealing Agents Market Analysis 20.21.1. By Product 20.21.2. By End User 20.22. South Africa Hemostasis and Tissue Sealing Agents Market Analysis 20.22.1. By Product 20.22.2. By End User 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Concentration 21.3. Market Share Analysis of Top Players 21.4. Market Presence Analysis 21.4.1. By Regional footprint of Players 21.4.2. Product foot print by Players 21.4.3. Channel Foot Print by Players 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep dive 22.3.1. Advance Medical Solution (AMS) Group Plc 22.3.1.1. Overview 22.3.1.2. Product Portfolio 22.3.1.3. Profitability by Market Segments (Product/Channel/Region) 22.3.1.4. Sales Footprint 22.3.1.5. Strategy Overview 22.3.2. B Braun Medical, Inc. 22.3.2.1. Overview 22.3.2.2. Product Portfolio 22.3.2.3. Profitability by Market Segments (Product/Channel/Region) 22.3.2.4. Sales Footprint 22.3.2.5. Strategy Overview 22.3.3. Baxter 22.3.3.1. Overview 22.3.3.2. Product Portfolio 22.3.3.3. Profitability by Market Segments (Product/Channel/Region) 22.3.3.4. Sales Footprint 22.3.3.5. Strategy Overview 22.3.4. Biomet, Inc. 22.3.4.1. Overview 22.3.4.2. Product Portfolio 22.3.4.3. Profitability by Market Segments (Product/Channel/Region) 22.3.4.4. Sales Footprint 22.3.4.5. Strategy Overview 22.3.5. C R Bard, Inc. 22.3.5.1. Overview 22.3.5.2. Product Portfolio 22.3.5.3. Profitability by Market Segments (Product/Channel/Region) 22.3.5.4. Sales Footprint 22.3.5.5. Strategy Overview 22.3.6. Cohera Medical, Inc. 22.3.6.1. Overview 22.3.6.2. Product Portfolio 22.3.6.3. Profitability by Market Segments (Product/Channel/Region) 22.3.6.4. Sales Footprint 22.3.6.5. Strategy Overview 22.3.7. Cohesion Technologies, Inc. 22.3.7.1. Overview 22.3.7.2. Product Portfolio 22.3.7.3. Profitability by Market Segments (Product/Channel/Region) 22.3.7.4. Sales Footprint 22.3.7.5. Strategy Overview 22.3.8. Covidien Plc. 22.3.8.1. Overview 22.3.8.2. Product Portfolio 22.3.8.3. Profitability by Market Segments (Product/Channel/Region) 22.3.8.4. Sales Footprint 22.3.8.5. Strategy Overview 22.3.9. CryoLife, Inc. 22.3.9.1. Overview 22.3.9.2. Product Portfolio 22.3.9.3. Profitability by Market Segments (Product/Channel/Region) 22.3.9.4. Sales Footprint 22.3.9.5. Strategy Overview 22.3.10. HyperBranch Medical Technology. 22.3.10.1. Overview 22.3.10.2. Product Portfolio 22.3.10.3. Profitability by Market Segments (Product/Channel/Region) 22.3.10.4. Sales Footprint 22.3.10.5. Strategy Overview 22.3.11. Integra Life Sciences Corporation 22.3.11.1. Overview 22.3.11.2. Product Portfolio 22.3.11.3. Profitability by Market Segments (Product/Channel/Region) 22.3.11.4. Sales Footprint 22.3.11.5. Strategy Overview 22.3.12. Johnson & Johnson 22.3.12.1. Overview 22.3.12.2. Product Portfolio 22.3.12.3. Profitability by Market Segments (Product/Channel/Region) 22.3.12.4. Sales Footprint 22.3.12.5. Strategy Overview 22.3.13. MIL Laboratories Pvt., Ltd. 22.3.13.1. Overview 22.3.13.2. Product Portfolio 22.3.13.3. Profitability by Market Segments (Product/Channel/Region) 22.3.13.4. Sales Footprint 22.3.13.5. Strategy Overview 22.3.14. Pfizer, Inc. 22.3.14.1. Overview 22.3.14.2. Product Portfolio 22.3.14.3. Profitability by Market Segments (Product/Channel/Region) 22.3.14.4. Sales Footprint 22.3.14.5. Strategy Overview 22.3.15. Smith & Nephew 22.3.15.1. Overview 22.3.15.2. Product Portfolio 22.3.15.3. Profitability by Market Segments (Product/Channel/Region) 22.3.15.4. Sales Footprint 22.3.15.5. Strategy Overview 23. Assumptions and Acronyms Used 24. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Hemostasis and Tissue Sealing Agents Market Volume (‘000 Units) Analysis and Opportunity Assessment 2017–2027, By Product
Table 02: Global Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Product
Table 03: Global Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End User
Table 04: Global Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Region
Table 05: North America Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 06: North America Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Product
Table 07: North America Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End User
Table 08: Latin America Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 09: Latin America Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Product
Table 10: Latin America Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End User
Table 11: Europe Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 12: Europe Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Product
Table 13: Europe Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End User
Table 14: South Asia Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 15: South Asia Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Product
Table 16: South Asia Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End User
Table 17: East Asia Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 18: East Asia Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Product
Table 19: East Asia Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End User
Table 20: Oceania Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 21: Oceania Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Product
Table 22: Oceania Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End User
Table 23: Middle East and Africa Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 24: Middle East and Africa Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Product
Table 25: Middle East and Africa Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Hemostasis and Tissue Sealing Agents Market Volume (in 000' Units) Analysis, 2017-2021
Figure 02: Global Hemostasis and Tissue Sealing Agents Market Volume Forecast (in 000' Units), 2022-2027
Figure 03: Hemostasis and Tissue Sealing Agents Pricing Analysis (US$) Per Product, By Region, 2021
Figure 04: Hemostasis and Tissue Sealing Agents Pricing Analysis (US$) Per Product, By Region, 2021
Figure 05: Global Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2017-2021
Figure 06: Global Hemostasis and Tissue Sealing Agents Market Value Forecast (US$ Mn), 2022-2027
Figure 07: Global Hemostasis and Tissue Sealing Agents Market Absolute $ Opportunity, 2022-2027
Figure 08: Global Hemostasis and Tissue Sealing Agents Market Share Analysis (%), By Product, 2022-2027
Figure 09: Global Hemostasis and Tissue Sealing Agents Market Y-o-Y Analysis (%), By Product, 2022-2027
Figure 10: Global Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis by Product, 2022-2027
Figure 11: Global Hemostasis and Tissue Sealing Agents Market Share Analysis (%), By End User, 2022-2027
Figure 12: Global Hemostasis and Tissue Sealing Agents Market Y-o-Y Analysis (%), By End User, 2022-2027
Figure 13: Global Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis by End User, 2022-2027
Figure 14: Global Hemostasis and Tissue Sealing Agents Market Share Analysis (%), By Region, 2022-2027
Figure 15: Global Hemostasis and Tissue Sealing Agents Market Y-o-Y Analysis (%), By Region, 2022-2027
Figure 16: Global Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis by Region, 2022-2027
Figure 17: North America Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 18: North America Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Figure 19: North America Hemostasis and Tissue Sealing Agents Market Value Share, By Country, 2022 (E)
Figure 20: North America Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2017-2021
Figure 21: North America Hemostasis and Tissue Sealing Agents Market Value Forecast (US$ Mn), 2022-2027
Figure 22: North America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis by Product, 2022-2027
Figure 23: North America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis by End User, 2022-2027
Figure 24: North America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis by Country, 2022-2027
Figure 25: Latin America Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 26: Latin America Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Figure 27: Latin America Hemostasis and Tissue Sealing Agents Market Value Share, By Country, 2022 (E)
Figure 28: Latin America Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2017-2021
Figure 29: Latin America Hemostasis and Tissue Sealing Agents Market Value Forecast (US$ Mn), 2022-2027
Figure 30: Latin America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis by Product, 2022-2027
Figure 31: Latin America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis by End User, 2022-2027
Figure 32: Latin America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis by Country, 2022-2027
Figure 33: Europe Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 34: Europe Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Figure 35: Europe Hemostasis and Tissue Sealing Agents Market Value Share, By Country, 2022 (E)
Figure 36: Europe Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2017-2021
Figure 37: Europe Hemostasis and Tissue Sealing Agents Market Value Forecast (US$ Mn), 2022-2027
Figure 38: Europe Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis by Product, 2022-2027
Figure 39: Europe Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis by End User, 2022-2027
Figure 40: Europe Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis by Country, 2022-2027
Figure 41: South Asia Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 42: South Asia Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Figure 43: South Asia Hemostasis and Tissue Sealing Agents Market Value Share, By Country, 2022 (E)
Figure 44: South Asia Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2017-2021
Figure 45: South Asia Hemostasis and Tissue Sealing Agents Market Value Forecast (US$ Mn), 2022-2027
Figure 46: South Asia Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis by Product, 2022-2027
Figure 47: South Asia Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis by End User, 2022-2027
Figure 48: South Asia Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis by Country, 2022-2027
Figure 49: East Asia Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 50: East Asia Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Figure 51: East Asia Hemostasis and Tissue Sealing Agents Market Value Share, By Country, 2022 (E)
Figure 52: East Asia Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2017-2021
Figure 53: East Asia Hemostasis and Tissue Sealing Agents Market Value Forecast (US$ Mn), 2022-2027
Figure 54: East Asia Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis by Product, 2022-2027
Figure 55: East Asia Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis by End User, 2022-2027
Figure 56: East Asia Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis by Country, 2022-2027
Figure 57: Oceania Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 58: Oceania Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Figure 59: Oceania Hemostasis and Tissue Sealing Agents Market Value Share, By Country, 2022 (E)
Figure 60: Oceania Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2017-2021
Figure 61: Oceania Hemostasis and Tissue Sealing Agents Market Value Forecast (US$ Mn), 2022-2027
Figure 62: Oceania Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis by Product, 2022-2027
Figure 63: Oceania Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis by End User, 2022-2027
Figure 64: Oceania Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis by Country, 2022-2027
Figure 65: Middle East and Africa Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 66: Middle East and Africa Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Figure 67: Middle East and Africa Hemostasis and Tissue Sealing Agents Market Value Share, By Country, 2022 (E)
Figure 68: Middle East and Africa Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2017-2021
Figure 69: Middle East and Africa Hemostasis and Tissue Sealing Agents Market Value Forecast (US$ Mn), 2022-2027
Figure 70: Middle East and Africa Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis by Product, 2022-2027
Figure 71: Middle East and Africa Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis by End User, 2022-2027
Figure 72: Middle East and Africa Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis by Country, 2022-2027
Figure 73: U. S. Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2022 & 2027
Figure 74: U. S. Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 75: U. S. Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Figure 76: Canada Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2022 & 2027
Figure 77: Canada Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 78: Canada Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Figure 79: Mexico Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2022 & 2027
Figure 80: Mexico Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 81: Mexico Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Figure 82: Brazil Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2022 & 2027
Figure 83: Brazil Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 84: Brazil Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Figure 85: U. K. Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2022 & 2027
Figure 86: U. K. Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 87: U. K. Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Figure 88: Germany Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2022 & 2027
Figure 89: Germany Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 90: Germany Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Figure 91: France Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2022 & 2027
Figure 92: France Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 93: France Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Figure 94: Italy Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2022 & 2027
Figure 95: Italy Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 96: Italy Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Figure 97: Spain Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2022 & 2027
Figure 98: Spain Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 99: Spain Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Figure 100: Russia Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2022 & 2027
Figure 101: Russia Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 102: Russia Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Figure 103: China Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2022 & 2027
Figure 104: China Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 105: China Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Figure 106: Japan Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2022 & 2027
Figure 107: Japan Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 108: Japan Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Figure 109: South Korea Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2022 & 2027
Figure 110: South Korea Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 111: South Korea Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Figure 112: India Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2022 & 2027
Figure 113: India Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 114: India Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Figure 115: ASEAN Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2022 & 2027
Figure 116: ASEAN Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 117: ASEAN Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Figure 118: Australia Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2022 & 2027
Figure 119: Australia Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 120: Australia Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Figure 121: New Zealand Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2022 & 2027
Figure 122: New Zealand Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 123: New Zealand Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Figure 124: GCC Countries Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2022 & 2027
Figure 125: GCC Countries Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 126: GCC Countries Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Figure 127: Turkey Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2022 & 2027
Figure 128: Turkey Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 129: Turkey Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Figure 130: South Africa Hemostasis and Tissue Sealing Agents Market Value Analysis (US$ Mn), 2022 & 2027
Figure 131: South Africa Hemostasis and Tissue Sealing Agents Market Value Share, By Product, 2022 (E)
Figure 132: South Africa Hemostasis and Tissue Sealing Agents Market Value Share, By End User, 2022 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
At present, what valuation does the hemostasis and tissue sealing agents market enjoy?
Currently, the global market for hemostasis and tissue sealing agents is valued at US$ 5 billion.
At what rate is the global hemostasis and tissue sealing agents market expected to expand?
Global sales of hemostasis and tissue sealing agents are expected to rise at 8.5% CAGR from 2022 to 2027.
What is the projected value of the market for 2027?
The global market is expected to reach US$ 7.6 billion by 2027.
Which product type is highly popular in this market?
Sales of topical hemostats are expected to increase at 9.5% CAGR and reach US$ 5.5 billion by 2027.
What is China’s hemostasis and tissue sealing agents market size?
The China hemostasis and tissue sealing agents market is expected to reach US$ 1.6 billion by 2027.
Hemostasis and Tissue Sealing Agents Market